Halozyme Therapeutics Inc...
55.04
1.21 (2.25%)
At close: Jan 15, 2025, 10:23 AM

Halozyme Therapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018
Product Revenue 86.66M 72.70M 79.60M 86.57M 73.89M 1.71M 14.35M 48.00M 20.73M 25.53M 32.22M 60.32M 30.33M 57.25M 32.34M 33.04M 385.00K 13.74M 416.00K 15.28M 17.95M 6.38M 2.40M 571.00K 3.38M
Product Revenue Growth +19.20% -8.67% -8.05% +17.16% +4223.52% -88.09% -70.09% +131.59% -18.83% -20.75% -46.58% +98.85% -47.02% +77.04% -2.12% +8481.30% -97.20% +3203.37% -97.28% -14.88% +181.44% +165.57% +320.67% -83.10% n/a
Collaborative Agreements Revenue 48.36M 16.70M 28.39M 15.03M 35.41M 60.79M 61.16M 61.43M 46.30M 22.14M 25.05M 30.36M 21.77M 32.45M 9.05M 6.34M 8.15M 22.69M 29.20M 5.76M 30.61M n/a n/a n/a n/a
Collaborative Agreements Revenue Growth +189.55% -41.16% +88.84% -57.55% -41.76% -0.60% -0.43% +32.67% +109.12% -11.61% -17.50% +39.48% -32.93% +258.70% +42.78% -22.22% -64.10% -22.30% +407.03% -81.18% n/a n/a n/a n/a n/a
Royalty Revenue 155.06M 120.59M 122.05M 114.43M 111.74M 99.64M 105.98M 99.55M 85.34M 69.61M 58.56M 45.78M 36.92M 32.00M 23.93M 15.85M 16.82M 17.23M 16.61M 18.11M 8.39M n/a n/a n/a n/a
Royalty Revenue Growth +28.58% -1.20% +6.66% +2.41% +12.14% -5.98% +6.46% +16.65% +22.61% +18.85% +27.93% +23.98% +15.40% +33.71% +51.02% -5.80% -2.37% +3.74% -8.27% +115.82% n/a n/a n/a n/a n/a
Upfront fees Revenue 27.00M 10.51M n/a 0 0 0 0 0 5.00M 25.00M 2.00M 40.00M 16.77M 30.00M 0 7.26M 0 13.00M 0 10.00M 30.00M n/a n/a n/a n/a
Upfront fees Revenue Growth +156.87% n/a n/a n/a n/a n/a n/a -100.00% -80.00% +1150.00% -95.00% +138.52% -44.10% n/a -100.00% n/a -100.00% n/a -100.00% -66.67% n/a n/a n/a n/a n/a
bulk rHuPH20 Revenue 31.49M n/a n/a 37.00M 27.13M 22.07M 21.32M 19.26M 25.06M 16.45M 18.86M 24.06M n/a 26.71M 3.85M 3.91M 3.77M 17.14M 24.59M 1.47M 5.08M n/a n/a n/a n/a
bulk rHuPH20 Revenue Growth n/a n/a n/a +36.37% +22.95% +3.51% +10.70% -23.14% +52.34% -12.80% -21.61% n/a n/a +593.82% -1.48% +3.74% -78.02% -30.31% +1572.99% -71.07% n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012
Switzerland Revenue 109.89M 119.14M 93.07M 57.14M 42.79M 35.20M 18.90M
Switzerland Revenue Growth -7.76% +28.01% +62.89% +33.52% +21.57% +86.24% n/a
United States Revenue 40.48M 196.27M 52.29M 77.15M 31.40M 19.00M 22.70M
United States Revenue Growth -79.38% +275.34% -32.22% +145.72% +65.25% -16.30% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 41.24M 35.71M 35.13M 37.61M 35.27M 38.95M 37.36M 37.75M 34.47M 57.48M 13.83M 13.77M 13.17M 12.32M 11.06M 10.43M 11.70M 10.97M 12.63M 23.93M 17.98M 17.34M 18.01M 18.03M 14.86M 14.35M 13.56M 14.77M 13.33M 13.10M 12.62M 12.23M 11.60M 11.22M 10.81M 10.59M 10.23M 9.81M 9.40M
Selling, General, and Administrative Revenue Growth +15.49% +1.64% -6.58% +6.63% -9.45% +4.26% -1.04% +9.52% -40.03% +315.47% +0.44% +4.59% +6.88% +11.41% +6.06% -10.90% +6.62% -13.12% -47.21% +33.09% +3.70% -3.71% -0.14% +21.31% +3.56% +5.88% -8.23% +10.82% +1.74% +3.85% +3.17% +5.41% +3.37% +3.84% +2.05% +3.55% +4.20% +4.42% n/a
Research and Development Revenue 18.46M 21.04M 19.11M 21.34M 17.32M 19.73M 17.98M 22.57M 16.70M 15.48M 11.85M 10.11M 8.49M 8.07M 9.01M 7.38M 7.75M 8.95M 10.16M 45.11M 30.45M 33.91M 31.33M 36.65M 35.54M 40.09M 37.98M 41.38M 33.99M 38.34M 36.94M 41.35M 33.86M 35.53M 40.10M 27.75M 27.61M 21.20M 16.68M
Research and Development Revenue Growth -12.26% +10.08% -10.43% +23.18% -12.20% +9.72% -20.33% +35.09% +7.89% +30.63% +17.26% +19.11% +5.17% -10.43% +22.07% -4.74% -13.45% -11.88% -77.48% +48.12% -10.19% +8.24% -14.52% +3.12% -11.34% +5.56% -8.22% +21.72% -11.34% +3.80% -10.67% +22.11% -4.69% -11.40% +44.53% +0.49% +30.27% +27.04% n/a